Sergi D - Search Results

1

GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer.

Pizzuti L, Sergi D, Mandoj C, Antoniani B, Sperati F, Chirico A, Di Lauro L, Valle M, Garofalo A, Vizza E, Corrado G, Tomao F, Rinaldi M, Carpano S, Maugeri-Saccà M, Conti L, Digiesi G, Marchetti P, De Maria R, Giordano A, Barba M, Carosi MA, Vici P. Pizzuti L, et al. Among authors: sergi d. J Cell Physiol. 2018 Feb;233(2):1396-1401. doi: 10.1002/jcp.26023. Epub 2017 Jul 14. J Cell Physiol. 2018. PMID: 28542798

2

[High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].

Conti F, Carpano S, Sergi D, Di Lauro L, Amodio A, Vici P, Abbate MI, Ferranti FR, Viola G, Botti C, Foggi P, Sperduti I, Lopez M. Conti F, et al. Among authors: sergi d. Clin Ter. 2007 Jul-Aug;158(4):331-41. Clin Ter. 2007. PMID: 17953285 Clinical Trial. Italian.

3

A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines.

Vici P, Di Lauro L, Sergi D, Foggi P, Viola G, Mottolese M, Giotta F, Fattoruso SI, Corsetti S, Giannarelli D, Botti C, Lopez M. Vici P, et al. Among authors: sergi d. Oncology. 2008;75(3-4):175-81. doi: 10.1159/000163056. Epub 2008 Oct 8. Oncology. 2008. PMID: 18841031 Clinical Trial.

4

Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.

Vici P, Viola G, Botti C, Rossi S, Vitucci C, Corsetti S, Di Lauro L, Sergi D, Foggi P, Perri P, Tirelli C, Mottolese M, Fattoruso SI, Lopez M. Vici P, et al. Among authors: sergi d. Clin Ter. 2008 Nov-Dec;159(6):449-52. Clin Ter. 2008. PMID: 19169607 Review.

5

Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.

Vici P, Viola G, Rossi S, Botti C, Vitucci C, Sergi D, Ferranti FR, Saracca E, Di Lauro L, Corsetti S, Foggi P, Fattoruso SI, Lopez M. Vici P, et al. Among authors: sergi d. Clin Ter. 2008 Nov-Dec;159(6):453-6. Clin Ter. 2008. PMID: 19169608 Review.

6

Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma.

Di Lauro L, Giacinti L, Arena MG, Sergi D, Fattoruso SI, Giannarelli D, Lopez M. Di Lauro L, et al. Among authors: sergi d. J Exp Clin Cancer Res. 2009 Mar 9;28(1):34. doi: 10.1186/1756-9966-28-34. J Exp Clin Cancer Res. 2009. PMID: 19267943 Free PMC article. Clinical Trial.

7

Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.

Vici P, Giotta F, DI Lauro L, Brandi M, Gebbia V, Foggi P, Lorusso V, Vitucci C, Sergi D, Fattoruso SI, Giannarelli D, Viola G, Corsetti S, Colucci G, Lopez M. Vici P, et al. Among authors: sergi d. Anticancer Res. 2009 May;29(5):1841-5. Anticancer Res. 2009. PMID: 19443414 Free article. Clinical Trial.

8

Recent advances in the adjuvant treatment of early breast cancer.

De Luca C, Vici P, Carpano S, Sergi D, Viola G, Corsetti S, Toglia G, Pinnarò P, Vizza E, Amodio A, Paoletti G, Lopez M. De Luca C, et al. Among authors: sergi d. Clin Ter. 2009;160(4):299-306. Clin Ter. 2009. PMID: 19795084 Review.

9

[Adjuvant chemotherapy in hormone-receptor positive HER2-negative early breast cancer].

Lopez M, Di Lauro L, Viola G, Foggi P, Conti F, Corsetti S, Sergi D, Botti C, Di Filippo F, Vici P. Lopez M, et al. Among authors: sergi d. Clin Ter. 2009;160(6):481-8. Clin Ter. 2009. PMID: 20198292 Italian.

10

[Psyche and cancer].

Lopez M, Cauchi C, Sergi D, Amodio A, Paoletti G, Vici P, Di Lauro L. Lopez M, et al. Among authors: sergi d. Clin Ter. 2010;161(1):69-75. Clin Ter. 2010. PMID: 20393684 Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters